Advertisement
Advertisement
FLGT
Fulgent Genetics, Inc. Common Stock
16.37
USDSponsored
-0.32
-1.92%
Mar 26, 15:59 UTC -4
Closed
Pre-Market
16.39
+0.02
+0.13%
FLGT Earnings Reports
Positive Surprise Ratio
FLGT beat 29 of 38 last estimates.
76%
Next Report
Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$69.85M
/-$0.22
Implied change from Q4 25 (Revenue/ EPS)
-16.18%
/-237.50%
Implied change from Q1 25 (Revenue/ EPS)
-4.91%
/-650.00%
Fulgent Genetics, Inc. Common Stock earnings per share and revenue
On Feb 27, 2026, FLGT reported earnings of 0.16 USD per share (EPS) for Q4 25, beating the estimate of 0.03 USD, resulting in a 422.88% surprise. Revenue reached 83.34 million, compared to an expected 87.09 million, with a -4.31% difference. The market reacted with a -38.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 69.85 million USD, implying an decrease of -237.50% EPS, and decrease of -16.18% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.24
Actual
-$0.27
Surprise
-11.57%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Fulgent Genetics, Inc. Common Stock reported EPS of $0.16, beating estimates by 422.88%, and revenue of $83.34M, -4.31% below expectations.
How did the market react to Fulgent Genetics, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -38.09%, changed from $24.76 before the earnings release to $15.33 the day after.
When is Fulgent Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Fulgent Genetics, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of $69.85M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement